DDI-DrugBank.d686.s0 >> Thiabendazole may compete with other drugs, such as theophylline, for sites of metabolism in the liver, thus elevating the serum levels of such compounds to potentially toxic levels. >> 0-12,52-63
DDI-DrugBank.d686.s1 >> Therefore, when concomitant use of thiabendazole and xanthine derivatives is anticipated, it may be necessary to monitor blood levels and/or reduce the dosage of such compounds. >> 35-47,53-72
DDI-DrugBank.d686.s2 >> Such concomitant use should be administered under careful medical supervision.
